CXCL10 and non-small cell lung carcinoma: The authors had previously demonstrated a role of TRIB3 in promoting STAT3 phosphorylation/activation in NSCLC (98), with targeted therapeutic degradation of TRIB3 promoting STAT1 protein stability and resultant Cxcl10 transcription (71).